Buccal mucosa Biopsy - Small <1cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Small mucosal biopsy from oral cavity.

₹296₹423

30% OFF

Buccal Mucosa Biopsy - Small <1cm

Why is it done?
- Purpose: Histopathological examination of small tissue samples (<1cm) obtained from the buccal mucosa (inner cheek lining) to diagnose mucosal disorders, suspected malignancies, infectious diseases, and inflammatory conditions
- Primary Indications: Persistent oral ulcers or lesions, suspected oral malignancy or dysplasia, chronic inflammatory conditions (lichen planus, pemphigus), erythematous patches or white lesions (leukoplakia), unexplained swelling or nodules, systemic diseases affecting oral mucosa, recurrent apthous ulcers, or suspected infectious conditions
- When Performed: When clinical examination reveals suspicious lesions, abnormal tissue changes have persisted beyond 2-3 weeks, malignancy is suspected, differential diagnosis is needed, or monitoring progression of known oral conditions
Normal Range
- Normal Histological Findings: Stratified squamous epithelium without dysplasia, normal cellular architecture with intact basement membrane, absence of malignant cells, normal inflammatory response if any, appropriate maturation of epithelial cells from basal to surface layers
- Interpretation: Negative/Normal indicates benign tissue with no evidence of malignancy, dysplasia, or significant pathology. Report typically includes descriptive pathology findings classified using standardized grading systems
- Units: Qualitative histopathological diagnosis with descriptive microscopic findings and grade classification (benign, dysplastic changes grades I-III, malignant, or specific disease diagnosis)
Interpretation
- Benign Findings: Normal mucosa, hyperplasia, hyperkeratosis, chronic inflammation, reactive changes, benign neoplasms (fibromas, papillomas) - indicates no malignant transformation
- Dysplastic Changes: Mild dysplasia (Grade I) - Low-grade changes, requires close follow-up; Moderate dysplasia (Grade II) - Intermediate risk, needs repeat biopsy or excision; Severe dysplasia/CIS (Grade III) - High risk for malignant transformation, may require treatment
- Malignant Findings: Invasive carcinoma (squamous cell carcinoma most common), adenocarcinoma, melanoma, lymphoma - requires immediate treatment planning and staging investigations
- Specific Conditions: Oral lichen planus (reticular, erosive, atrophic), pemphigus/pemphigoid (autoimmune findings), fungal infections (candidiasis - pseudohyphae), bacterial infections, systemic disease involvement
- Factors Affecting Interpretation: Adequacy of specimen sampling, proper fixation and processing, tissue staining quality, clinical correlation essential, presence of artifact or crush artifact may complicate interpretation, immunohistochemical stains may enhance diagnostic accuracy
Associated Organs
- Primary Organ System: Oral cavity and buccal mucosa (part of integumentary and digestive systems), stratified squamous epithelium, underlying connective tissue and submucosa
- Diseases Diagnosed: Oral squamous cell carcinoma (OSCC), oral dysplasia, oral lichen planus, pemphigus vulgaris, bullous pemphigoid, oral candidiasis, erythema multiforme, lupus erythematosus (oral manifestations), scleroderma, Sjögren's syndrome, oral submucous fibrosis
- Related Conditions: Oral cancer and metastatic disease, tobacco and alcohol-related changes, viral infections (HPV, herpes simplex, EBV), nutritional deficiencies affecting oral mucosa, immunosuppression, graft-versus-host disease
- Potential Complications/Risks: Delayed diagnosis if biopsy not performed, malignant lesions may progress to advanced stages, systemic disease may worsen if underlying conditions remain undiagnosed, risk of infection if malignancy present and untreated
Follow-up Tests
- If Malignancy Diagnosed: TNM staging CT/MRI of head and neck, positron emission tomography (PET-CT), immunohistochemical staining for tumor markers, HPV testing if applicable, imaging for metastatic workup (chest X-ray, abdominal ultrasound)
- If Dysplasia Diagnosed: Repeat biopsy (6 weeks - 3 months for mild dysplasia), wider excisional biopsy for higher grades, close clinical follow-up every 3-6 months, potentially enhanced visualization techniques (toluidine blue, methylene blue)
- If Autoimmune/Inflammatory Condition: Immunofluorescence studies (direct and indirect), serum autoantibody testing (ANA, anti-desmoglein, anti-desmocollin), systemic workup (rheumatologic evaluation), dermatology or rheumatology consultation
- If Infectious Disease Suspected: Fungal culture, bacterial culture and sensitivity, viral PCR testing, direct fluorescent antibody (DFA) testing, special stains (PAS, Gram, Giemsa)
- Complementary Tests: Complete blood count (CBC) with differential, comprehensive metabolic panel, imaging studies, endoscopy if needed, consultation with oral surgery or oncology
- Monitoring Frequency: Benign findings: Clinical follow-up as needed; Dysplasia: Every 3-6 months; Malignancy: Per oncology protocol (typically every 1-3 months initially, then every 3-6 months)
Fasting Required?
- Fasting: No - Fasting is NOT required for buccal mucosa biopsy
- Patient Preparation: Routine oral hygiene can be performed, rinse mouth gently with water before procedure, avoid eating hard or sticky foods immediately before biopsy (within 1 hour), patient may eat and drink normally
- Medications: Continue regular medications unless otherwise instructed, anticoagulants (warfarin, aspirin, NSAIDs) should be discussed with physician prior to procedure, anticoagulant continuation depends on individual risk/benefit assessment
- Special Instructions: Inform provider of bleeding disorders or anticoagulant use, disclose any oral infections or cold sores, avoid alcohol consumption 24 hours before procedure, local anesthetic will be administered, procedure takes 5-10 minutes, minimal discomfort expected with local anesthesia
- Post-Procedure Care: Avoid hot foods/drinks for 2-3 hours, gentle rinsing with warm salt water starting next day, avoid disturbing the biopsy site, mild discomfort expected (managed with over-the-counter analgesics), report excessive bleeding or infection to provider

How our test process works!